您好，欢迎来到试剂信息网！ [登录] [免费注册]
试剂信息网
发布求购
位置：首页 > 产品库 > Angiotensin 1/2(5-7)
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
Angiotensin 1/2(5-7)
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
Angiotensin 1/2(5-7)图片
包装与价格：
包装价格(元)
5mg电议
10mg电议
25mg电议

产品介绍

Vasoconstrictor

别名H2N-Ile-His-Pro-OH
Canonical SMILESN[C@@H]([C@H](C)CC)C(N[C@@H](CC1=CNC=N1)C(N2CCC[C@@H]2C(O)=O)=O)=O
分子式C17H27N5O4
分子量365.43
溶解度≥ 36.5mg/mL in DMSO
储存条件Store at -20℃
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

Angiotensin 1/2 (5-7), (C17H27N5O4), a peptide with the sequence H2N-Ile-His-Pro-OH, MW=365.43. Angiotensin is a peptide hormone that causes vasoconstriction and a subsequent increase in blood pressure. Angiotensin is an oligopeptide and is a hormone and a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system1. Angiotensin I is formed by the action of renin on angiotensinogen. Renin is produced in the kidneys in response to renal sympathetic activity, decreased intrarenal blood pressure at the juxtaglomerular cells2, or decreased delivery of Na+ and Cl- to the macula densa3.If less Na+ is sensed by the macula densa, renin release by juxtaglomerular cells is increased.Renin cleaves the peptide bond between the leucine (Leu) and valine (Val) residues on angiotensinogen, creating the ten-amino acid peptide (des-Asp) angiotensin I Angiotensin I appears to have no biological activity and exists solely as a precursor to angiotensin 2.

References:
1. Basso N, Terragno NA (December 2001). "History about the discovery of the renin-angiotensin system". Hypertension 38 (6): 1246–9.
2. Skurk T, Lee YM, Hauner H (May 2001). "Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture". Hypertension 37 (5): 1336–40.
3. Williams GH, Dluhy RG (2008). "Chapter 336: Disorders of the Adrenal Cortex". In Loscalzo J, Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL. Harrison's principles of internal medicine. McGraw-Hill Medical.